Alkermes (ALKS) Tops Q3 EPS by 11c; Boosts FY13 Outlook
Alkermes (NASDAQ: ALKS) reported Q3 EPS of $0.34, $0.11 better than the analyst estimate of $0.23. Revenue ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
